Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • human_urostor
    Junior Member
    • Mar 2016
    • 1

    #1

    Cuffdiff confidence intervals - relative quantitation

    Hi all,

    I have not found any answers to this kind of question anywhere so I have to ask.
    I've done RNA-seq and analyzed it in tophat/cuffdiff (then cummeRbund but this is irrelevant here). I also did RT-qPCR on some genes to cross-validate my findings. My reference gene for RT-qPCR was one that was moderately, evenly expressed in all my samples (judging from FPKM). The expression level of all of my other genes was therefore noted as a fraction of the expression level of my reference gene in the same sample (RQ).

    To make a figure comparing the results from those two methods, I want to present the expression levels for genes of interest from RNA-seq as fractions of expression level of my reference gene too.

    My problem is: how to calculate the uncertainty in the relative FPKM value? From the research I have done, if FDR is left at 0.05, cuffdiff reports 95% confidence intervals calculated as in this paper: http://bioinformatics.oxfordjournals.../1026.abstract

    I have found two methods of calculating uncertainty when dividing two values.
    Method one: http://www.math-mate.com/chapter34_4.shtml (subsection "Division with two numbers with large errors – long method")
    Method two (let R be the relative expression): https://en.wikipedia.org/wiki/Propag...ce_measurement

    The problem with the first one is that (using my mathematical common sense) I would get a 95%*95%=90% CI, the resulting uncertainties seem too huge, and it seems not to be supported by any literature. The problem with the second method is that I need to use standard deviation, and the 95% CI is not exactly the SD.

    I would appreciate any help.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...